Juno Diagnostics

About:

Juno Diagnostics is a healthcare technology company developing the next generation cell-free DNA-based noninvasive prenatal test solutions.

Website: https://junodx.com

Top Investors: Perceptive Advisors, Charge Ventures, Colle Capital Partners, Saltagen Ventures, Bioverge

Description:

Juno Diagnostics is a health technology company democratizing access to high-value genetic information. The company is developing simple, cost-effective devices that enable point-of-need genetic testing. It was founded in 2017 and is based in San Diego, California.

Total Funding Amount:

$25M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2017-08-01

Contact Email:

team(AT)junodx.com

Founders:

Dirk van den Boom, Jim Chauvapun

Number of Employees:

11-50

Last Funding Date:

2021-05-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai